Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP363114.RAbvK7yKrx7jQ6L1jTUZsau94zCkrAXMVwpaqxhtVc_UY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP363114.RAbvK7yKrx7jQ6L1jTUZsau94zCkrAXMVwpaqxhtVc_UY130_assertion type Assertion NP363114.RAbvK7yKrx7jQ6L1jTUZsau94zCkrAXMVwpaqxhtVc_UY130_head.
- NP363114.RAbvK7yKrx7jQ6L1jTUZsau94zCkrAXMVwpaqxhtVc_UY130_assertion description "[Furthermore, low E2F-1 expression and p16INK4A inactivation may serve as prognostic markers for patients with this type of lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363114.RAbvK7yKrx7jQ6L1jTUZsau94zCkrAXMVwpaqxhtVc_UY130_provenance.
- NP363114.RAbvK7yKrx7jQ6L1jTUZsau94zCkrAXMVwpaqxhtVc_UY130_assertion evidence source_evidence_literature NP363114.RAbvK7yKrx7jQ6L1jTUZsau94zCkrAXMVwpaqxhtVc_UY130_provenance.
- NP363114.RAbvK7yKrx7jQ6L1jTUZsau94zCkrAXMVwpaqxhtVc_UY130_assertion SIO_000772 10803523 NP363114.RAbvK7yKrx7jQ6L1jTUZsau94zCkrAXMVwpaqxhtVc_UY130_provenance.
- NP363114.RAbvK7yKrx7jQ6L1jTUZsau94zCkrAXMVwpaqxhtVc_UY130_assertion wasDerivedFrom befree-20150227 NP363114.RAbvK7yKrx7jQ6L1jTUZsau94zCkrAXMVwpaqxhtVc_UY130_provenance.
- NP363114.RAbvK7yKrx7jQ6L1jTUZsau94zCkrAXMVwpaqxhtVc_UY130_assertion wasGeneratedBy ECO_0000203 NP363114.RAbvK7yKrx7jQ6L1jTUZsau94zCkrAXMVwpaqxhtVc_UY130_provenance.